Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Svitlana V. Mikhalap"'
Autor:
Maria Y Yurchenko, L. M. Shlapatska, Edward A. Clark, Svetlana P. Sidorenko, Svitlana V. Mikhalap, Ganna G Berdova, Kim E. Nichols, Olga V. Yurchenko
Publikováno v:
Blood. 104:4063-4070
The CD150 receptor is expressed on activated T and B lymphocytes, dendritic cells, and monocytes. A TxYxxV/I motif in the CD150 cytoplasmic tail can bind different SH2-containing molecules, including tyrosine and inositol phosphatases, Src family kin
Autor:
Svitlana V. Mikhalap, Larisa M. Shlapatska, Anna G. Berdova, Che-Leung Law, Edward A. Clark, Svetlana P. Sidorenko
Publikováno v:
The Journal of Immunology. 162:5719-5727
CDw150, a receptor up-regulated on activated T or B lymphocytes, has a key role in regulating B cell proliferation. Patients with X-linked lymphoproliferative disease have mutations in a gene encoding a protein, DSHP/SAP, which interacts with CDw150
Autor:
Vasyl F. Chekhun, S. P. Sidorenko, Svitlana V. Mikhalap, M. Y. Yurchenko, L. M. Shlapatska, Y. M. Akimov
Publikováno v:
Bioinformatics of Genome Regulation and Structure ISBN: 9781475746136
Cell surface receptor CD150 represents a novel group of receptors that could transmit both activating and inhibiting signals regulating the cell fate. The CD150 subfamily members are involved in the development and pathogenesis of severe immunodefici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1ab1b83a1c9349f7ca4f0f8a981284a
https://doi.org/10.1007/978-1-4419-7152-4_22
https://doi.org/10.1007/978-1-4419-7152-4_22
Autor:
Kim E. Nichols, Oleksander M. Zelensky, Svetlana P. Sidorenko, Svitlana V. Mikhalap, Berdova Ag, Theodore J. Yun, L. M. Shlapatska, Edward A. Clark
Publikováno v:
Europe PubMed Central
CD150 (SLAM/IPO-3) is a cell surface receptor that, like the B cell receptor, CD40, and CD95, can transmit positive or negative signals. CD150 can associate with the SH2-containing inositol phosphatase (SHIP), the SH2-containing protein tyrosine phos
Autor:
Blythe D Sather, Svitlana V Mikhalap, Miguel E Moreno-Garcia, Karen Sommer, Larysa M Shlapatska, Svetlana P Sidorenko, David J Rawlings
Publikováno v:
The Journal of Immunology. 182:88.19-88.19
Development of therapies for diffuse large B-cell lymphomas (DLBCL) requires a precise knowledge of signaling aberrations essential for tumor development. In normal B cells, the B cell receptor (BCR) initiates intracellular signals crucial for the su